Second Antibody FDA-Approved Against Multiple Myeloma December 1, 2015December 14, 2022 Arthur N. Brodsky, PhD
Nivolumab Becomes First FDA-Approved Checkpoint Blockade for Kidney Cancer November 24, 2015December 14, 2022 Arthur N. Brodsky, PhD
First Monoclonal Antibody for Multiple Myeloma Receives FDA Approval November 20, 2015December 14, 2022 Alexandra Mulvey
FDA Approves Immunotherapy to Help Prevent Relapse of Melanoma October 30, 2015December 14, 2022 Matthew Tontonoz
FDA Approves First in a New Class of Immunotherapies October 27, 2015December 14, 2022 Matthew Tontonoz